Page last updated: 2024-12-08

araloside a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chikusetsusaponin IV: an alpha-glucosidase ligand; isolated from Panax japonicus; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

araloside A: structure given in first source; isolated from the root bark of Aralia chinesis L. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AraliagenusA plant genus in the family Araliaceae.[MeSH]AraliaceaeThe ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound. Flowers are five-parted and arranged in compound flat-topped umbels. The fruit is a berry or (rarely) a drupe (a one-seeded fruit). It is well known for plant preparations used as adaptogens (immune support and anti-fatigue).[MeSH]
AraliagenusA plant genus in the family Araliaceae.[MeSH]AraliaceaeThe ginseng plant family of the order Apiales, subclass Rosidae, class Magnoliopsida. Leaves are generally alternate, large, and compound. Flowers are five-parted and arranged in compound flat-topped umbels. The fruit is a berry or (rarely) a drupe (a one-seeded fruit). It is well known for plant preparations used as adaptogens (immune support and anti-fatigue).[MeSH]

Cross-References

ID SourceID
PubMed CID197091
MeSH IDM0194359
PubMed CID10079497
CHEMBL ID1773982
CHEBI ID67975
SCHEMBL ID5927782
MeSH IDM0194359

Synonyms (23)

Synonym
chikusetsusaponin iv
chikusetsusaponin 4
araloside
oleanoside e
beta-d-glucopyranosiduronic acid, (3beta)-28-(beta-d-glucopyranosyloxy)-28-oxoolean-12-en-3-yl 4-o-alpha-l-arabinofuranosyl-
7518-22-1
(2s,3s,4r,5r,6s)-6-[[(6ar,6bs,8as,12ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-[(2s,3r,4r,5s)-3,4-dihydroxy-5-(h
unii-32bf7y358g
32bf7y358g ,
araloside a
C17540
chikusetsusaponin-iv
CHEMBL1773982
chebi:67975 ,
SCHEMBL5927782
AKOS037515071
HY-N2115
(2s,3s,4r,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-[(2s,3r,4r,5s)-3,4-di
Q15410268
CS-0018636
MS-31733
(3beta)-28-(beta-d-glucopyranosyloxy)-28-oxoolean-12-en-3-yl 4-o-alpha-l-arabinofuranosyl-beta-d-glucopyranosiduronic acid
DTXSID801045681
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
triterpenoid saponinA terpene glycoside in which the terpene moiety is a triterpenoid.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID1441290Inhibition of CaCl2 activated hyaluronidase (unknown origin) using hyaluronic acid as substrate preincubated for 20 mins followed by substrate addition measured after 10 mins by colorimetric method2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Discovery of hyaluronidase inhibitors from natural products and their mechanistic characterization under DMSO-perturbed assay conditions.
AID595752Cytotoxicity against human DU145 cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID595753Cytotoxicity against human A549 cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID1441292Ratio of IC50 for CaCl2 activated hyaluronidase (unknown origin) to IC50 for hyaluronidase (unknown origin) using hyaluronic acid as substrate preincubated for 20 mins followed by CaCl2 activation2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Discovery of hyaluronidase inhibitors from natural products and their mechanistic characterization under DMSO-perturbed assay conditions.
AID1441287Inhibition of CaCl2 activated hyaluronidase (unknown origin) up to 400 uM using hyaluronic acid as substrate preincubated for 20 mins followed by substrate addition measured after 10 mins in presence of up to 15% DMSO by colorimetric method2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Discovery of hyaluronidase inhibitors from natural products and their mechanistic characterization under DMSO-perturbed assay conditions.
AID595749Inhibition of fMLP/CB-stimulated superoxide anion generation in human neutrophils at 30 uM relative to control2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID1441288Inhibition of hyaluronidase (unknown origin) using hyaluronic acid as substrate preincubated for 20 mins followed by substrate addition measured after 40 mins by colorimetric method2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Discovery of hyaluronidase inhibitors from natural products and their mechanistic characterization under DMSO-perturbed assay conditions.
AID595754Cytotoxicity against human HCT8 cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID595751Cytotoxicity against human KB cells assessed as growth inhibition after 3 days by sulforhodamine B assay2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
AID1441289Inhibition of hyaluronidase (unknown origin) using hyaluronic acid as substrate preincubated for 20 mins followed by CaCl2 activation for 20 mins and subsequent substrate addition measured after 10 mins by colorimetric method2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Discovery of hyaluronidase inhibitors from natural products and their mechanistic characterization under DMSO-perturbed assay conditions.
AID1441291Inhibition of CaCl2 activated hyaluronidase (unknown origin) using hyaluronic acid as substrate preincubated for 20 mins followed by substrate addition measured after 10 mins in presence of Triton-X-100 by colorimetric method2017Bioorganic & medicinal chemistry letters, 04-01, Volume: 27, Issue:7
Discovery of hyaluronidase inhibitors from natural products and their mechanistic characterization under DMSO-perturbed assay conditions.
AID595750Inhibition of fMLP/CB-activated human neutrophil degranulation assessed as inhibition of elastase release at 30 uM using MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide as a substrate after 5 mins relative to control2011Journal of natural products, Apr-25, Volume: 74, Issue:4
Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (9.09)18.2507
2000's1 (9.09)29.6817
2010's7 (63.64)24.3611
2020's2 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.98 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]